Mark L. Evans

10.4k total citations · 1 hit paper
184 papers, 6.3k citations indexed

About

Mark L. Evans is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Mark L. Evans has authored 184 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Endocrinology, Diabetes and Metabolism, 86 papers in Surgery and 70 papers in Genetics. Recurrent topics in Mark L. Evans's work include Diabetes Management and Research (110 papers), Pancreatic function and diabetes (83 papers) and Diabetes and associated disorders (68 papers). Mark L. Evans is often cited by papers focused on Diabetes Management and Research (110 papers), Pancreatic function and diabetes (83 papers) and Diabetes and associated disorders (68 papers). Mark L. Evans collaborates with scholars based in United Kingdom, United States and Austria. Mark L. Evans's co-authors include Roman Hovorka, Malgorzata E. Wilinska, Hood Thabit, Daniel Flanagan, Stephanie A. Amiel, Lora K. Heisler, Lalantha Leelarathna, Robert S. Sherwin, Sara Hartnell and Janet M. Allen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Mark L. Evans

177 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

2022 108 citations Lalantha Leelarathna, Mark L. Evans et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Mark L. Evans

Since Specialization

Citations

This map shows the geographic impact of Mark L. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Evans more than expected).

Fields of papers citing papers by Mark L. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Evans. The network helps show where Mark L. Evans may publish in the future.

Co-authorship network of co-authors of Mark L. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Evans. A scholar is included among the top collaborators of Mark L. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Evans. Mark L. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study 2024 ·Acta Diabetologica ·(unknown), (unknown), Peter Lommer Kristensen, Jens J. Holst, Cees J. Tack, Rory J. McCrimmon, Simon Heller, Mark L. Evans, Bastiaan E. de Galan, Ulrik Pedersen‐Bjergaard	3
2	The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults 2024 ·Diabetologia ·M. Loredana Marcovecchio, Emile Hendriks, (unknown), Tadej Battelino, Thomas Danne, Mark L. Evans, Jesper Johannesen, Simranjeet Kaur, Mikael Knip, Lut Overbergh, Flemming Pociot, John A. Todd, Bart Van der Schueren, Linda S. Wicker, Mark Peakman, Chantal Mathieu	14
3	Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes 2024 ·Journal of Diabetes Science and Technology ·(unknown), Charlotte K. Boughton, Munachiso Nwokolo, (unknown), Sara Hartnell, Malgorzata E. Wilinska, (unknown), Janet M. Allen, Hood Thabit, Julia K. Mader, Lia Bally, Lalantha Leelarathna, Mark L. Evans, Roman Hovorka	1
4	Postprandial Glucose Excursions with Ultra-Rapid Insulin Analogs in Hybrid Closed-Loop Therapy for Adults with Type 1 Diabetes 2024 ·Diabetes Technology & Therapeutics ·Belma Haliloğlu, Charlotte K. Boughton, (unknown), Julia Ware, Munachiso Nwokolo, Hood Thabit, Julia K. Mader, Lia Bally, Lalantha Leelarathna, Malgorzata E. Wilinska, Janet M. Allen, Sara Hartnell, Mark L. Evans, Roman Hovorka	5
5	Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial 2023 ·Nature Medicine ·Aideen Daly, Charlotte K. Boughton, Munachiso Nwokolo, Sara Hartnell, Malgorzata E. Wilinska, (unknown), Mark L. Evans, Roman Hovorka	56
6	Patient‐reported outcomes for older adults on CamAPS FX closed loop system 2023 ·Diabetic Medicine ·(unknown), Sarah J. Hanes, Charlotte K. Boughton, Sara Hartnell, Hood Thabit, Womba Mubita, (unknown), (unknown), (unknown), Malgorzata E. Wilinska, Julia K. Mader, Parth Narendran, Lalantha Leelarathna, Mark L. Evans, Roman Hovorka, Korey K. Hood	8
7	Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes 2023 ·Diabetes Obesity and Metabolism ·(unknown), Javier Castañeda, Pratik Choudhary, (unknown), (unknown), (unknown), Charles Thivolet, Mark L. Evans, (unknown), (unknown), Simona de Portu, (unknown), John Shin, Tim van den Heuvel, Ohad Cohen, (unknown)	11
8	Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia 2023 ·Diabetologia ·Judit Castillo‐Armengol, Flavia Marzetta, (unknown), Christian Fledelius, Mark L. Evans, Alison D. McNeilly, Rory J. McCrimmon, Mark Ibberson, Bernard Thorens	5
9	Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes 2022 ·Nature Communications ·Jiayuan Zhang, Fiona Hamey, Dominik Trzupek, (unknown), (unknown), Leila Godfrey, Jennie H. M. Yang, Marcin Ł. Pękalski, Jane Kennet, Frank Waldron-Lynch, Mark L. Evans, Timothy Tree, Linda S. Wicker, John A. Todd, Ricardo C. Ferreira	18
10	Hyperinsulinaemic–hypoglycaemic glucose clamps in human research: a systematic review of the literature 2021 ·Diabetologia ·(unknown), (unknown), Peter Lommer Kristensen, Cees J. Tack, Rory J. McCrimmon, Simon Heller, Mark L. Evans, Stephanie A. Amiel, Thomas R. Pieber, Bastiaan E. de Galan, Ulrik Pedersen‐Bjergaard	12
11	Closed‐loop insulin delivery in end‐of‐life care: a case report 2019 ·Diabetic Medicine ·Charlotte K. Boughton, Lia Bally, Sara Hartnell, Malgorzata E. Wilinska, Anthony P. Coll, Mark L. Evans, Christoph Stettler, Roman Hovorka	6
12	Hypoglycaemia incidence and recovery during home use of hybrid closed‐loop insulin delivery in adults with type 1 diabetes 2018 ·Diabetes Obesity and Metabolism ·Yue Ruan, Lia Bally, Hood Thabit, Lalantha Leelarathna, Sara Hartnell, Martin Tauschmann, Malgorzata E. Wilinska, Mark L. Evans, Julia K. Mader, Harald Kojzar, Sibylle Dellweg, Carsten Benesch, Sabine Arnolds, Thomas R. Pieber, Roman Hovorka	18
13	Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care 2018 ·New England Journal of Medicine ·Lia Bally, Hood Thabit, Sara Hartnell, (unknown), Yue Ruan, Malgorzata E. Wilinska, Mark L. Evans, Maria M. Wertli, Anthony P. Coll, Christoph Stettler, Roman Hovorka	145
14	A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5) 2018 ·Diabetes Obesity and Metabolism ·David C. Klonoff, Mark L. Evans, Wendy Lane, Hans‐Peter Kempe, Éric Renard, J. Hans DeVries, Tina Graungaard, (unknown), (unknown), Tadej Battelino	57
15	Faster insulin action is associated with improved glycaemic outcomes during closed‐loop insulin delivery and sensor‐augmented pump therapy in adults with type 1 diabetes 2017 ·Diabetes Obesity and Metabolism ·Yue Ruan, Hood Thabit, Lalantha Leelarathna, Sara Hartnell, Malgorzata E. Wilinska, Martin Tauschmann, Sibylle Dellweg, Carsten Benesch, Julia K. Mader, Manuel Holzer, Harald Kojzar, Mark L. Evans, Thomas R. Pieber, Sabine Arnolds, Roman Hovorka	8
16	Bolusing frequency and amount impacts glucose control during hybrid closed‐loop 2017 ·Diabetic Medicine ·Lia Bally, Hood Thabit, Yue Ruan, Julia K. Mader, Harald Kojzar, Sibylle Dellweg, Carsten Benesch, Sara Hartnell, Lalantha Leelarathna, Malgorzata E. Wilinska, Mark L. Evans, Sabine Arnolds, Thomas R. Pieber, Roman Hovorka	9
17	Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial 2013 ·Critical Care ·Lalantha Leelarathna, Shane English, Hood Thabit, Karen Caldwell, Janet M. Allen, Kavita Kumareswaran, Malgorzata E. Wilinska, Marianna Nodale, (unknown), Mark L. Evans, Rowan Burnstein, Roman Hovorka	87
18	Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study 2013 ·Diabetes Care ·Kavita Kumareswaran, Hood Thabit, Lalantha Leelarathna, Karen Caldwell, Daniela Elleri, Janet M. Allen, Marianna Nodale, Malgorzata E. Wilinska, Mark L. Evans, Roman Hovorka	41
19	Hypoglycaemia and glucose sensing 1997 ·Diabetologia ·Dustin Baker, Mark L. Evans, (unknown), R. S. Sherwin	20
20	Maintenance of brood stock, larval rearing and nursery techniques used to grow Macrobrachium rosenbergii in waste-heat discharge waters of an electric generating station in New Jersey (U.S.A.) 1977 ·Institutional Archive of Ifremer (French Research Institute for Exploitation of the Sea) ·A.F. Eble, Mark L. Evans, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact